Alcon Inc.
As of Oct 22, 2026, Alcon is in Stage 4, the downtrend phase, now in week 4 (since Sep 30, 2026). It closed at $70.63, 18.6% below its 52-week high and below its 200-day average, which is falling.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is ALC early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
ALC among Medical Instruments & Supplies29th of 51 by relative strength
All 51 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | PLSE | Stage 2 · wk 34 | 98 | +1.3% |
| 2 | PDEX | Stage 2 · wk 36 | 97 | −13.3% |
| 3 | HBIO | Stage 2 · wk 11 | 95 | +3.6% |
| 4 | ATRC | Stage 2 · wk 10 | 89 | −1.1% |
| 5 | WST | Stage 2 · wk 24 | 82 | +4.8% |
| 6 | BDX | Stage 2 · wk 11 | 81 | +9.8% |
| 7 | ICUI | Stage 3 · wk 1 | 81 | +3.1% |
| 8 | OSUR | Stage 3 · wk 8 | 75 | −4.8% |
| …29 | ALC | Stage 4 · wk 4 | 49 | +8.0% |
Alcon: quick answers
What stage is Alcon in?
As of Oct 22, 2026, Alcon (ALC) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 30, 2026 and is in week 4. What the four stages mean
Is Alcon in an uptrend?
No. Alcon is in a Stage 4 downtrend. It trades 2.0% below its 200-day average, which is falling.
How far is Alcon from its 52-week high?
Alcon closed at $70.63 on Oct 22, 2026, 18.6% below its 52-week high of $86.76. Its 52-week low is $62.02.
How has Alcon performed over the past year?
As of Oct 22, 2026, Alcon is down 6.3% over the past year and down 8.5% so far in 2026.
Which sector and industry is Alcon in?
Alcon is in the Medical Instruments & Supplies industry, part of the Health Care sector.
About this companyHealth Care· Medical Instruments & Supplies
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.